Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Feb;95(2):329-331.
doi: 10.1002/ccd.28600. Epub 2019 Nov 19.

The hypothesis of an increased mortality following paclitaxel coated device use in peripheral vascular interventions (and the emerging era of meta-analysis based evidence)

Bernardo Cortese  1 , Fernando Alfonso  2 , Dario Pellegrini  3   4 , Krishna R Sing  5 , Juan F Granada  6
Affiliations
Editorial

The hypothesis of an increased mortality following paclitaxel coated device use in peripheral vascular interventions (and the emerging era of meta-analysis based evidence)

Bernardo Cortese et al. Catheter Cardiovasc Interv. 2020 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7:e011245.
    1. Schneider PA, Laird JR, Tepe G, et al. Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial. Circ Cardiovasc Interv. 2018;11:e005891.
    1. Schneider PA, Laird JR, Doros G, et al. Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis. J Am Coll Cardiol. 2019;73:2550-2563.
    1. Secemsky EA, Kundi H, Weinberg I, et al. Association of survival with femoropopliteal artery revascularization with drug-coated devices. JAMA Cardiol. 2019;4:332-340.
    1. Taichman DB, Sahni P, Pinborg A, et al. Data sharing statements for clinical trials-a requirement of the International Committee of Medical Journal Editors. N Engl J Med. 2017;376:2277-2279.

LinkOut - more resources